Bio Solution바이오솔루션
086820 · KOSDAQ · ₩086820 · 바이오솔루션
₩5,650▲ ₩60 (1.07%)End-of-day · Oct 27, 2026 · End-of-day prices.
Filings
- Investor relations (IR) event기업설명회(IR)개최Oct 23, 2026Open on DART
Predicted impact: Low
- Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
- Amended: Convertible bond issue decision[기재정정]주요사항보고서(전환사채권발행결정)Aug 6, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획승인신청등결정) (동종 연골세포 스페로이드(스페로큐어)의 제1/2a상 임상시험계획 승인)Jul 14, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Apr 29, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Apr 17, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Apr 8, 2026Open on DART
- Annual general meeting results정기주주총회결과Mar 27, 2026Open on DART
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 27, 2026Open on DART
- Audit report submitted감사보고서제출Mar 19, 2026Open on DART
- Annual report (Dec 2025)사업보고서 (2025.12)Mar 19, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Mar 18, 2026Open on DART
- Notice of Reason for Concentrated Shareholders' Meeting Date주주총회집중일개최사유신고Mar 12, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Mar 12, 2026Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 12, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 12, 2026Open on DART
- Exercise of Conversion Rights전환청구권행사Mar 11, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Feb 24, 2026Open on DART
- Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Feb 12, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획승인신청등결정) (펠렛형 동종 연골세포치료제(카티로이드)의 호주 제1/2상 임상시험계획 승인)Jan 14, 2026Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 16, 2025Open on DART
- Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 14, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획승인신청) (동종 연골세포 스페로이드(스페로큐어)의 제1/2a상 임상시험계획 승인신청)Nov 10, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획승인신청) (펠렛형 동종 연골세포치료제(카티로이드)의 호주 제1/2상 임상시험계획 승인신청)Sep 17, 2025Open on DART
- Investor relations (IR) event기업설명회(IR)개최Aug 25, 2025Open on DART
- Half-year report (Jun 2025)반기보고서 (2025.06)Aug 14, 2025Open on DART
- Decision on Loan Extension금전대여결정Jul 1, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항 (펠렛형 동종 연골세포치료제(카티로이드)의 제1/2상 임상시험계획 승인신청 반려)Jun 5, 2025Open on DART
- Investor relations (IR) event기업설명회(IR)개최Jun 5, 2025Open on DART
- Investor relations (IR) event기업설명회(IR)개최May 30, 2025Open on DART
- [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고May 29, 2025Open on DART
- Ex-Rights (Bonus Issue)권리락 (무상증자)May 26, 2025Open on DART
- Quarterly report (Mar 2025)분기보고서 (2025.03)May 15, 2025Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정May 13, 2025Open on DART
- Trading halt주권매매거래정지 (무상증자)May 13, 2025Open on DART
- Bonus share issue decision주요사항보고서(무상증자결정)May 13, 2025Open on DART
- Investor relations (IR) event기업설명회(IR)개최May 9, 2025Open on DART
- Investor relations (IR) event기업설명회(IR)개최May 9, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험결과) (카티라이프(바솔자가연골유래연골세포치료제)의 미국 2상 임상시험 최종결과보고서 수령)May 7, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항 (카티라이프(바솔자가연골유래연골세포)의 한국 식품의약품안전처 품목 변경허가 획득)Apr 29, 2025Open on DART
- Annual general meeting results정기주주총회결과Mar 28, 2025Open on DART
- Notice on Grant of Stock Purchase Options주식매수선택권부여에관한신고Mar 28, 2025Open on DART
- Amended: Annual report (Dec 2024)[기재정정]사업보고서 (2024.12)Mar 28, 2025Open on DART
- Audit report submitted감사보고서제출Mar 20, 2025Open on DART
- Annual report (Dec 2024)사업보고서 (2024.12)Mar 20, 2025Open on DART
- [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고Mar 18, 2025Open on DART
- Notice of Reason for Concentrated Shareholders' Meeting Date주주총회집중일개최사유신고Mar 13, 2025Open on DART
- Shareholders' meeting called주주총회소집결의Mar 13, 2025Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 13, 2025Open on DART
Titles in Korean until English translations are added.
Also known as: Bio Solution / 바이오솔루션 / 086820 / KRX:086820
Source: KRX statistical information